Cabot Corp (CBT) Position Trimmed by Bbva Compass Bancshares Inc.

Bbva Compass Bancshares Inc. trimmed its holdings in shares of Cabot Corp (NYSE:CBT) by 7.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,049 shares of the specialty chemicals company’s stock after selling 512 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Cabot were worth $252,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in CBT. Jane Street Group LLC acquired a new stake in Cabot during the 3rd quarter valued at approximately $272,000. Ipswich Investment Management Co. Inc. acquired a new stake in Cabot during the 4th quarter valued at approximately $79,000. Meeder Asset Management Inc. lifted its stake in Cabot by 28.2% during the 4th quarter. Meeder Asset Management Inc. now owns 1,049 shares of the specialty chemicals company’s stock valued at $45,000 after acquiring an additional 231 shares during the period. Peregrine Capital Management LLC lifted its stake in shares of Cabot by 49.8% in the 4th quarter. Peregrine Capital Management LLC now owns 188,021 shares of the specialty chemicals company’s stock valued at $8,074,000 after purchasing an additional 62,487 shares during the period. Finally, IFP Advisors Inc lifted its stake in shares of Cabot by 723.5% in the 4th quarter. IFP Advisors Inc now owns 1,087 shares of the specialty chemicals company’s stock valued at $46,000 after purchasing an additional 955 shares during the period. 87.04% of the stock is owned by hedge funds and other institutional investors.

CBT opened at $43.88 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.34 and a debt-to-equity ratio of 0.55. Cabot Corp has a 1 year low of $39.57 and a 1 year high of $67.80. The firm has a market capitalization of $2.57 billion, a P/E ratio of 10.89, a PEG ratio of 1.01 and a beta of 1.40.

Cabot (NYSE:CBT) last posted its earnings results on Monday, May 6th. The specialty chemicals company reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. Cabot had a net margin of 8.13% and a return on equity of 19.06%. The firm had revenue of $844.00 million during the quarter, compared to analysts’ expectations of $868.00 million. During the same period in the previous year, the business posted $1.04 EPS. The business’s revenue was up 3.2% compared to the same quarter last year. As a group, equities research analysts forecast that Cabot Corp will post 4.13 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Friday, May 31st will be paid a $0.35 dividend. This is a boost from Cabot’s previous quarterly dividend of $0.33. This represents a $1.40 annualized dividend and a dividend yield of 3.19%. The ex-dividend date of this dividend is Thursday, May 30th. Cabot’s payout ratio is currently 32.75%.

Several equities analysts recently issued reports on the stock. ValuEngine upgraded shares of Cabot from a “strong sell” rating to a “sell” rating in a research note on Thursday, April 18th. Zacks Investment Research upgraded shares of Cabot from a “sell” rating to a “hold” rating in a research note on Tuesday, April 9th. Finally, TheStreet cut shares of Cabot from a “b-” rating to a “c+” rating in a research note on Friday, March 22nd. Two research analysts have rated the stock with a sell rating and three have given a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $77.67.

TRADEMARK VIOLATION NOTICE: This story was first posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.baseballdailydigest.com/news/2019/05/17/cabot-corp-cbt-position-trimmed-by-bbva-compass-bancshares-inc.html.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and compounds of carbon black and rubber.

Further Reading: What is Put Option Volume?

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corp (NYSE:CBT).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.